Tenders

Rv Electricity Purchase 2023

Open House Discount Contracts 2023-09

Open House Original Discount Agreements 2023-25 ​​- Rilpivirine (Dosage Form: Film-Coated Tablets)

Open House Original Discount Agreements 2023-24 - Rilpivirine (Dosage Form: Depot Suspension for Injection)

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Filgotinib, Atc L04aa45 for the Period October 15, 2023 - October 31, 2025

Conclusion of a Non-Exclusive Framework Agreement for Investigations and Appraisals in the Open House Procedure of the West Branch

Oh-Biologica-2023-25 ​​- Etanercept

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Saso - Security Assessment and System Optimisation (ex-post)

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.